cancer, blood, bone marrow, tissue, malignant, leukocytes, peripheral, myeloproliferative, lymphoproliferative, granulocytes, Drug Views, drugs, Medical, Information, Health, Drugs, Conditions, Pharmacy, Pills http://www.drugviews.com/articles.php en-us Ateom.com - Website Power Tools Thu, 02 Sep 2010 06:16:08 -0400 http://www.drugviews.com/articles.php?t=Cellerant-Therapeutics-signs-contract-with-BARDA-to-develop-CLT-008-therapy-for-ARS life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced a $50,000 Quality Service Guarantee.]]> Fri, 27 Aug 2010 06:08:54 -0400 http://www.drugviews.com/articles.php?t=Cord-Blood-America-announces-Quality-Service-Guarantee-for-stem-cell-engraft cancer biology, Fox Chase Cancer Center will host the Philadelphia Chromosome Symposium: Past, Present and Future, on September 28, 2010, from 8 a.m. to 7 p.m. at The Chemical Heritage Foundation, 315 Chestnut Street, Philadelphia. The event marks the 50th anniversary of the discovery of the first genetic abnormality associated with cancer, and the first to ]]> Wed, 25 Aug 2010 09:54:00 -0400 http://www.drugviews.com/articles.php?t=Fox-Chase-Cancer-Center-to-host-Philadelphia-Chromosome-Symposium chronic health condition after the procedure, according to a recent study published online in Blood, the journal of the American Society of Hematology.]]> Thu, 19 Aug 2010 04:24:00 -0400 http://www.drugviews.com/articles.php?t=Hematopoietic-cell-transplantation-survivors-report-of-chronic-health-condition-after-procedure one key reason why blood stem cells are susceptible to developing the genetic mutations that can lead to adult leukemia. Their finding also may explain, they say, why some other age-related hematological disorders develop.The study, reported in "Cell Stem Cell" and reviewed in Cell Stem Cell and Cell, opens a new frontier for studying the molecular underpinnings ]]> Tue, 17 Aug 2010 03:03:00 -0400 http://www.drugviews.com/articles.php?t=Scientists-identify-possible-therapeutic-strategy-for-reducing-leukemia-risk-from-chemotherapy study published online in Blood, the journal of the American Society of Hematology.]]> Mon, 16 Aug 2010 01:59:02 -0400 http://www.drugviews.com/articles.php?t=Fertility-preservation-may-be-unsafe-for-leukemia-patients-Study health benefits after a dozen years lifting radiators and iron in a factory for Visteon Corp. But the car-parts maker won bankruptcy-court approval to terminate those retiree benefits, just months after Ms. Roberts, 62 years old, was diagnosed with multiple myeloma and leukemia.]]> Fri, 13 Aug 2010 05:54:18 -0400 http://www.drugviews.com/articles.php?t=Companies-reorganizing-under-Chapter-11-battle-with-former-employees-over-lifetime-health-benefits Tue, 10 Aug 2010 00:41:32 -0400 http://www.drugviews.com/articles.php?t=Athersys-second-quarter-revenues-increase-to-1-9-million cancer agent, CPI-613. Cornerstone is a leader in the discovery and development of cancer therapies that capitalize upon and disrupt the unique metabolic processes of cancer cells.]]> Fri, 06 Aug 2010 04:57:00 -0400 http://www.drugviews.com/articles.php?t=Cornerstone-Pharmaceuticals-includes-Mary-Crowley-Research-Centers-in-CPI-613-clinical-trials cancer of the white blood cells. The CLL research is made possible by funding from the National Institutes of Health and will enable scientists to survey the whole transcriptomes ]]> Thu, 05 Aug 2010 08:19:48 -0400 http://www.drugviews.com/articles.php?t=Life-Technologies-UCSD-Moores-Cancer-Center-to-use-SOLiD-4-technology-to-study-CLL treatment of cancer, today announced its financial results for the second quarter and six months ended June 30, 2010.]]> Thu, 05 Aug 2010 08:08:35 -0400 http://www.drugviews.com/articles.php?t=Micromet-second-quarter-2010-total-revenues-increase-to-6-5-million life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today said that it has had positive movement on two financial obligations that further strengthen its balance sheet.]]> Thu, 05 Aug 2010 07:48:59 -0400 http://www.drugviews.com/articles.php?t=Cord-Blood-America-strengthens-balance-sheet-by-reducing-financial-obligations cancer drugs.]]> Mon, 02 Aug 2010 10:09:34 -0400 http://www.drugviews.com/articles.php?t=BGU-Professor-awarded-grant-to-develop-target-specific-anti-cancer-drugs Fri, 30 Jul 2010 08:25:14 -0400 http://www.drugviews.com/articles.php?t=Pivotal-PINNACLE-trial-results-of-VELCADE-in-patients-with-relapsed-refractory-MCL-released drug development operations in Houston, Texas, announced today that the first patient has been dosed in a Phase I study of its cancer drug candidate, Liposomal Grb-2 (L-Grb-2 or BP-100-1.01), in patients with Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia (ALL) or Myelodysplastic Syndrome (MDS).]]> Fri, 30 Jul 2010 04:53:24 -0400 http://www.drugviews.com/articles.php?t=Bio-Path-commences-dosing-in-Liposomal-Grb-2-Phase-I-cancer-study A type of prostate cell that has been largely ignored by cancer researchers can, in fact, trigger malignant prostate cancer, according to new studies by Howard Hughes Medical Institute (HHMI) scientists and their colleagues.]]> Fri, 30 Jul 2010 01:26:34 -0400 http://www.drugviews.com/articles.php?t=Prostate-basal-cell-can-spawn-tumors-in-prostate-gland-Research life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced highlights for the six-month period ended June 30, 2010. The Company believes the period was the most significant and eventful in its history.]]> Thu, 29 Jul 2010 07:58:18 -0400 http://www.drugviews.com/articles.php?t=Cord-Blood-America-announces-highlights-for-6-month-period-ended-June-30-2010 testing services resource for pathologists, oncologists and the biopharmaceutical industry, today reported financial results for the second quarter ended June 30, 2010. Second quarter 2010 net revenue was $28.7 million, a 21 percent increase over the $23.7 million net revenue in the 2009 second quarter and a sequential increase of nearly eight percent over the ]]> Thu, 29 Jul 2010 05:24:49 -0400 http://www.drugviews.com/articles.php?t=Clarient-second-quarter-net-revenue-increases-21-to-28-7-million online today in Blood, the journal of the American Society of Hematology. AML is the most common form of acute leukemia among adults and is a rapidly growing cancer of the bone ]]> Thu, 29 Jul 2010 04:25:54 -0400 http://www.drugviews.com/articles.php?t=Intensive-chemotherapy-may-benefit-elderly-patients-with-acute-myeloid-leukemia care for chronic myeloid leukemia (CML).]]> Thu, 29 Jul 2010 02:50:58 -0400 http://www.drugviews.com/articles.php?t=New-test-to-predict-suitable-treatment-for-chronic-myeloid-leukemia-patients